Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › hexaminolevulinate

hexaminolevulinate

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of hexaminolevulinate

3 trials tracked of hexaminolevulinate: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 108 citations.

3Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Other / NA 1
  1. Phase 3 A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting Completed · 108 cited
  2. Phase 3 Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer Completed
  3. N/A Near Infrared Fluorescence Imaging for Bladder Cancer Detection Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Hexaminolevulinate blue light cystoscopy detects more bladder cancer lesions than white light cystoscopy in a Chinese phase III study
Urology Cohort
Hexaminolevulinate blue light cystoscopy detects more bladder cancer lesions than white light cystoscopy in a Chinese phase III study A Special Blue Light Catches Bladder Cancer Standard Scopes Miss
This prospective, comparative, within-patient controlled multicenter phase III bridging study enrolled 158 patients with bladder cancer in C…
A special blue-light scope caught bladder cancer in 43% of patients that standard white-light scopes missed during screening.
Frontiers Apr 14, 2026